Aim: To find out the vocal outcome of conservative management and temporary medialization in unilateral vocal cord palsy (UVCP) and their effectiveness in reducing the need for permanent medialization.
INTRODUCTION
The human voice serves a great deal of communicative function and is the best expression of emotions. Voice change can have a lot of functional, emotional, psychological, and professional impacts on a person's life.
Unilateral vocal cord palsy is a commonly encountered condition and these patients can be asymptomatic in one-third of the cases or present with dysphonia, aspiration, vocal fatigue, and rarely potential respiratory compromise. In addition to the disruption of the physiological laryngeal function, it can also interfere with the quality of life, especially in professionals for whom voice quality is important.
Vocal cord movement is brought about by the intrinsic laryngeal muscles, innervated mainly by the recurrent laryngeal nerve (RLN) except the cricothyroid muscle which is innervated by the external branch of the superior laryngeal nerve, both being branches of the vagus nerve. Vocal cord palsy refers to vocal cord immobility and can result from central nervous system disorders, vagal nuclear or supranuclear lesions, vagus nerve lesions itself, or RLN lesions. If the nerve injury is transient, the patients experience complete recovery of the vocal cord function. However, if the injury is severe, and complete conduction block develops, the patient may not regain appropriate vocal fold movement, in spite of signs of reinnervation on electromyography. Recovery may be complete or incomplete with compensation. The effect on voice can be evaluated by perceptual assessment like the GRBAS scale and Consensus Auditory Perceptual Evaluation-Voice (CAPE-V) scales, subjective evaluation in the form of VHI as well as assessment of aerodynamic parameters like MPT.
The treatment is initially conservative including speech therapy, pushing exercises, swallowing therapy, and electrical stimulation. Temporary medialization using injection laryngoplasty can be done before attempting a permanent vocal cord medialization with Type I IJOPL medialization thyroplasty. Arytenoid adduction can be used to supplement a Type I thyroplasty if the posterior glottic gap is large. Laryngeal reinnervation procedures are designed to bypass the main trunk of the nerve and address the individual intrinsic laryngeal muscles directly or at the most distal branches of the RLN to provide improvement in laryngeal muscle tone and mass.
The aim of this study was to find the vocal outcome of conservative management of UVCP and temporary medialization procedures and the eventual need for a permanent medialization thyroplasty.
MATERIALS AND METHODS
The study was conducted as a prospective study in the Department of ENT of our tertiary care hospital. A total of 30 adult patients presenting with change in voice, vocal fatigue, aspiration or respiratory distress, and having UVCP on 70° rigid endoscopy were enrolled in our study, after ruling out any structural lesion of the vocal cords or laryngeal malignancy. A high-resolution computed tomography (CT) scan from the skull base to mediastinum was done to find out the etiology, along with detailed history and clinical examination. The patients without any relevant history of neck, skull base or thoracic surgery, or prior intubation with a normal CT scan were labeled to have an idiopathic vocal cord palsy.
Auditory perceptual evaluation of voice was done using the GRBAS scale with five parameters: Overall grade or severity (G), roughness of the voice (R), breathiness (B), asthenia (A), and strain (S). The quality of the voice was then given a scoring of 0 to 3 for each parameter such that 0 = normal, 1 = mild, 2 = moderate, 3 = severe. An overall GRBAS score was obtained.
Aerodynamic voice assessment was done using the MPT. The patient was asked to take a deep breath and sustain the vowel sound "a" for as long as possible at a comfortable pitch and loudness on one exhalation, and without straining. The time was recorded in seconds, and MPT was calculated as the average of three attempts.
Voice Handicap Index was used to assess the subjective feeling of handicap that a patient experiences due to his/her voice problem. The patients were given a questionnaire containing 30 questions of three categories: Functional, physical, and emotional with 10 questions in each category and were asked to give their responses using a score from 0 to 4 such that 0 = never, 1 = almost never, 2 = sometimes, 3 = almost always, and 4 = always. The total score was used as the VHI.
All the patients were initially treated with speech therapy, swallowing therapy, instructed about vocal hygiene, and started on proton pump inhibitors. Patients with tuberculosis were started on anti-tuberculosis treatment and those with other infections like skull base osteomyelitis were started on appropriate antibiotics. Patients were asked to follow-up at 3 months after their first visit, and GRBAS scoring, VHI scoring, and calculation of the MPT were done at the first visit as well as follow-up. At 3 months, the patients showing significant improvement, i.e., reduction in the GRBAS score of ≥5, increase in the MPT of ≥5 seconds, and reduction in the VHI ≥20 were continued on a conservative management, whereas patients failing to show improvement were then treated with temporary medialization using injection laryngoplasty with hyaluronic acid-Esthelis Basic (produced by Merz Pharmaceuticals, distributed in India by Aakaar Medical Technologies Pvt Ltd, formerly Coherent Medical Systems). Suspension microlaryngoscopy under general anesthesia was used for the procedure and 0.5 to 1 mL of hyaluronic acid was injected in the vibratory membrane to achieve the desired cord medialization. All the patients were further followed up for 3 months and at the end of total 6 months from the first visit, the patients were reassessed. The results were computed based on the voice outcome following the two modalities of treatment. The parameters of GRBAS and VHI were analyzed using the Wilcoxon signed rank test in the same group and the Mann-Whitney U-test for the comparison between the two groups of patients. The MPT was analyzed using Student's t-test. An assessment was also made regarding the need of a permanent medialization thyroplasty in patients with a poor voice outcome.
RESULTS
Of the 30 patients, 18 (60%) were males and 12 (40%) were females, the youngest being 19 years of age and the oldest being 68 years of age. The most common age group was 41 to 50 years. Eleven (36.67%) had right cord palsy, whereas 19 (63.33%) had left cord palsy. All the patients presented with hoarseness or change in voice. In addition to this, the most common symptom was vocal fatigue followed by aspiration. Twelve (40%) patients had idiopathic palsy. Postsurgical causes accounted for 33.33% (10) of the patients, among which 7 cases (23.33%) were postthyroidectomy. The other three cases were: coronary artery bypass graft (CABG), vagal paraganglioma, and vagal schwannoma excision. The other causes included tuberculous mediastinal lymphadenopathy in 4 (13.33%) patients, pulmonary tuberculosis, skull base osteomyelitis, skull base hyperostosis, and post traumatic in 1 (3.33%) patient each (Graph 1). At the end of 3 months, two groups were formed: the first of 20 patients who were continued on conservative management and the other of remaining 10 patients who were treated with injection laryngoplasty. Out of these 10 patients, 2 did not improve even after the temporary medialization procedure and were considered for permanent medialization by Type I thyroplasty. Both the groups were retrospectively assessed and compared from the baseline values.
Perceptual Evaluation
Baseline GRBAS score was comparable between the two groups (Graph 2 and Table 1 ). After 3 months, GRBAS score showed a significant fall of 54.1% (p < 0.05) in the conservative group and 8.9% in the temporary medialization group. After a total of 6 months, fall of 38.6% from the values at 3 months was observed in conservative management group as against 48.0% in temporary medialization group. The GRBAS scores showed a significant fall of 71.8% within the conservative treatment group and 52.7% within the temporary medialization group from the baseline. The difference between two groups at the end of 6 months was not significant.
Aerodynamic Analysis
Baseline MPT showed no significant difference between the two groups (Graph 3 and Table 2 ). At the end of 3 months, a significant rise (p < 0.05) of 1.30 times in the conservative group and 25.5% in the temporary medialization group was observed, compared with the baseline; significantly more (p < 0.05) in the conservative treatment group. At 6 months, a rise of 23.5% in the conservative group and 1.01 times in temporary medialization group from the respective values at 3 months was observed, the rise being significantly more (p < 0.05) in the temporary 
Subjective Analysis
Baseline VHI did not show a significant difference in both the groups (Graph 4 and Table 3 ). After 3 months, there was a significant fall (p < 0.05) of 29.1% in the conservative group and 2.6% in the temporary medialization group; significantly more (p < 0.05) in the conservative treatment group. After 6 months, a significant fall (p < 0.05) of 21.8%
in the conservative treatment group, and 42.2% (p < 0.05) in the temporary medialization group from the respective values at 3 months was noted; significantly more (p < 0.05) in the temporary medialization group. Thus, after 6 months of treatment, a significant fall (p < 0.05) of 44.6% in the conservative treatment group and 43.7% (p < 0.05) in the temporary medialization group from the baseline was observed. This was comparable between both the groups and there was no significant difference.
DISCUSSION
Unilateral vocal cord palsy is not a disease by itself but in majority of the cases it is a sign of an underlying disease or an iatrogenic injury. Dysphonia, which is the commonest symptom of unilateral cord palsy, is defined as a speech disorder resulting in impaired production of sounds by the vocal folds or any speech disorder involving problems of voice quality, pitch, or intensity under the diagnosis code 784.42 in ICD-9 (International Classification of Diseases, Ninth Revision). It has an adverse impact on a patient's social, occupational, and emotional aspects of life and leads to considerable loss of productivity from work absenteeism, especially in singers, teachers for whom the quality of voice is very important. Unilateral vocal cord palsy, if temporary, is known to recover completely by 9 to 12 months and can be aided by speech therapy and temporary medialization by injection laryngoplasty. In cases with permanent paralysis, attempts are directed at improving the voice, 3 Reiter and Brosch, 4 and Algonaim et al 5 have reported the mean age of their study cohort in the sixth decade of life, a decade more than our study. The difference in the age distribution between Indian and Western nations could be explained based on the higher life expectancy in the population of the affluent nations. In our study, out of 30 patients, 19 (63.33%) had a left-sided palsy and 11 (36.67%) patients had a rightsided palsy. Similarly, left-sided preponderance was also observed in studies conducted by Yumoto et al 6 from
Japan, Titche, 7 and Ramadhan et al. 8 On the left, the RLN passes inferior and posterior to the aortic arch and reverses its course to continue superiorly into the neck, whereas the right one loops behind the right subclavian artery and ascends superomedially toward the tracheoesophageal groove. Both travel just lateral to or within the tracheoesophageal groove and enter the larynx posterior to the cricothyroid joint. Low in the neck, the course of the right recurrent nerve is more oblique, lateral, and more prone to iatrogenic injury. 9 The left RLN is more frequently involved because the longer course of the nerve creates additional vulnerability, especially in the mediastinum in diseases like lung cancer, esophageal cancer, aortic aneurysm, lymphoma, tuberculosis, and mediastinal metastasis. Improved anesthetic and surgical techniques have allowed more aggressive treatment within the mediastinum, putting the nerve at further risk. 10 Similar to our study, Gupta et al 11 as well as Toutounchi et al 12 showed that the most common symptom of unilateral vocal cord paralysis was voice change. Vocal fatigue was not much highlighted in the other published studies, whereas our study noted that this was the second most common symptom because the patients often run out of air when the vocal cords fail to approximate. In the study carried out by Pavithran and Menon, 2 the incidence of UVCP following all nonthyroidectomy surgeries together (59.3%) was more than that of thyroidectomy (40.7%). The most common individual surgical procedure was still thyroidectomy followed by CABG. The percentage of the patients with idiopathic palsy and with iatrogenic palsy is similar to our study. Netterville et al 13 also found thyroid surgery to be the most common cause of iatrogenic RLN paralysis, thereby supporting the findings in our study. Benninger et al 14 have reported varying etiologies for UVCP and the changing trend with increasing incidence due to extralaryngeal malignancies and iatrogenic causes. A landmark study was done by Rosenthal et al 15 reporting nonthyroid surgeries to be the commonest cause of UVCP. Our study does not give data on the surgery responsible for the maximum cases in nonthyroidectomy group as the data was evenly distributed. The relative incidence of surgeries causing cord palsy depends on the referral pattern in the institution, demographic parameters as well as the surgical expertise which may have contributed to the differences seen in the etiology of UVCP in our institution as compared with other published studies. In our study, the patients failing to show satisfactory improvement at 3 months with conservative management alone were classified into the temporary medialization group, and injection laryngoplasty was done in these patients at 3 months. We used hyaluronic acid in a concentration of 22.5 mg/mL. The average maintenance period of hyaluronic acid is 9 to 12 months. It is tightly cross-linked, offers excellent biocompatibility, and has the closest match to native vocal cord viscoelasticity. 16, 17 Hertegård et al 18 18 reported that 60% of their patients had long-term benefit after hyaluronic acid injection. In our study, injection laryngoplasty at 3 months significantly improved the voice in 8 out of the 10 patients not responding to the conservative management alone, thereby avoiding permanent medialization. Yung et al 27 also concluded that the UVCP patients who underwent vocal fold injection to provide temporary medialization were statistically significantly less likely to undergo permanent medialization compared with those patients who were treated with conservative management only.
The initial treatment options for UVCP include voice therapy, observation for spontaneous return of function, or temporary medialization. Early medialization of a paralyzed vocal fold into a more favorable position can affect the final resting place of the vocal fold. This may be due to fibrosis caused by inflammation induced by the temporary agent or from reinnervation maintaining the medialized position after the injection material resorbs. If the paralysis does not resolve, permanent medialization laryngoplasty may be performed.
CONCLUSION
Unilateral vocal cord palsy occurs often due to an underlying condition or iatrogenic injury. Conservative management is the standard of care and should be started as soon as possible and given at least for 3 to 6 months. Procedure in the form of injection laryngoplasty at 3 months achieves better voice outcome in those not fully improved by the conservative management. Medialization thyroplasty should be suggested in patients who fail to show the desired improvement after temporary medialization using injection laryngoplasty.
CLINICAL SIgNIfICANCE
This study offers data on the management of patients in whom conservative approach alone for UVCP is not effective and their response to temporary medialization. The results help us to understand that an early intervention in these patients with injection laryngoplasty will prevent the requirement of permanent medialization procedures as well as give equally good outcomes compared with those benefiting with conservative management alone.
